Selected research
Industry Research
HPV Vaccines Industry Research Report 2026
Market perspective
The global HPV Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for HPV Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for HPV Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for HPV Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of HPV Vaccines include Johnson & Johnson, Merck, Pfizer, GlaxoSmithKline, Serum Institute, Sanofi Pasteur, MedImmune, Emergent BioSolutions and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global HPV Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
HPV Vaccines Market by Company
Johnson & Johnson
Merck
Pfizer
GlaxoSmithKline
Serum Institute
Sanofi Pasteur
MedImmune
Emergent BioSolutions
CSL
Astellas Pharma
HPV Vaccines Segment by Type
Adolescents
Adults
HPV Vaccines Segment by Application
Male
Female
HPV Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HPV Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of HPV Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of HPV Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of HPV Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Adolescents
- Adults
Applications
- Male
- Female
Companies covered
- Johnson & Johnson
- Merck
- Pfizer
- GlaxoSmithKline
- Serum Institute
- Sanofi Pasteur
- MedImmune
- Emergent BioSolutions
- CSL
- Astellas Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global HPV Vaccines Market Size (2021-2032)
- 2.2.2 Global HPV Vaccines Sales (2021-2032)
- 2.2.3 Global HPV Vaccines Market Average Price (2021-2032)
- 2.3 HPV Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Adolescents
- 2.3.3 Adults
- 2.4 HPV Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Male
- 2.4.3 Female
3 Market Competitive Landscape by Manufacturers
- 3.1 Global HPV Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global HPV Vaccines Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global HPV Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global HPV Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global HPV Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of HPV Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of HPV Vaccines, Product Type & Application
- 3.8 Global Manufacturers of HPV Vaccines, Established Date
- 3.9 Global HPV Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson HPV Vaccines Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Merck
- 4.2.1 Merck Company Information
- 4.2.2 Merck Business Overview
- 4.2.3 Merck HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck HPV Vaccines Product Portfolio
- 4.2.5 Merck Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer HPV Vaccines Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline HPV Vaccines Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 Serum Institute
- 4.5.1 Serum Institute Company Information
- 4.5.2 Serum Institute Business Overview
- 4.5.3 Serum Institute HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Serum Institute HPV Vaccines Product Portfolio
- 4.5.5 Serum Institute Recent Developments
- 4.6 Sanofi Pasteur
- 4.6.1 Sanofi Pasteur Company Information
- 4.6.2 Sanofi Pasteur Business Overview
- 4.6.3 Sanofi Pasteur HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sanofi Pasteur HPV Vaccines Product Portfolio
- 4.6.5 Sanofi Pasteur Recent Developments
- 4.7 MedImmune
- 4.7.1 MedImmune Company Information
- 4.7.2 MedImmune Business Overview
- 4.7.3 MedImmune HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 MedImmune HPV Vaccines Product Portfolio
- 4.7.5 MedImmune Recent Developments
- 4.8 Emergent BioSolutions
- 4.8.1 Emergent BioSolutions Company Information
- 4.8.2 Emergent BioSolutions Business Overview
- 4.8.3 Emergent BioSolutions HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Emergent BioSolutions HPV Vaccines Product Portfolio
- 4.8.5 Emergent BioSolutions Recent Developments
- 4.9 CSL
- 4.9.1 CSL Company Information
- 4.9.2 CSL Business Overview
- 4.9.3 CSL HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 CSL HPV Vaccines Product Portfolio
- 4.9.5 CSL Recent Developments
- 4.10 Astellas Pharma
- 4.10.1 Astellas Pharma Company Information
- 4.10.2 Astellas Pharma Business Overview
- 4.10.3 Astellas Pharma HPV Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Astellas Pharma HPV Vaccines Product Portfolio
- 4.10.5 Astellas Pharma Recent Developments
5 Global HPV Vaccines Market Scenario by Region
- 5.1 Global HPV Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global HPV Vaccines Sales by Region: 2021-2032
- 5.2.1 Global HPV Vaccines Sales by Region: 2021-2026
- 5.2.2 Global HPV Vaccines Sales by Region: 2027-2032
- 5.3 Global HPV Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global HPV Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global HPV Vaccines Revenue by Region: 2027-2032
- 5.4 North America HPV Vaccines Market Facts & Figures by Country
- 5.4.1 North America HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America HPV Vaccines Sales by Country (2021-2032)
- 5.4.3 North America HPV Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe HPV Vaccines Market Facts & Figures by Country
- 5.5.1 Europe HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe HPV Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe HPV Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific HPV Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific HPV Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific HPV Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America HPV Vaccines Market Facts & Figures by Country
- 5.7.1 South America HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America HPV Vaccines Sales by Country (2021-2032)
- 5.7.3 South America HPV Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa HPV Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa HPV Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa HPV Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa HPV Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global HPV Vaccines Sales by Type (2021-2032)
- 6.1.1 Global HPV Vaccines Sales by Type (2021-2032) & (k units)
- 6.1.2 Global HPV Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global HPV Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global HPV Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global HPV Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global HPV Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global HPV Vaccines Sales by Application (2021-2032)
- 7.1.1 Global HPV Vaccines Sales by Application (2021-2032) & (k units)
- 7.1.2 Global HPV Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global HPV Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global HPV Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global HPV Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global HPV Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 HPV Vaccines Value Chain Analysis
- 8.1.1 HPV Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 HPV Vaccines Production Mode & Process
- 8.2 HPV Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 HPV Vaccines Distributors
- 8.2.3 HPV Vaccines Customers
9 Global HPV Vaccines Analyzing Market Dynamics
- 9.1 HPV Vaccines Industry Trends
- 9.2 HPV Vaccines Industry Drivers
- 9.3 HPV Vaccines Industry Opportunities and Challenges
- 9.4 HPV Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst